http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107810006-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 2015-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107810006-B
titleOfInvention Composition for the treatment of insomnia
abstract In the present invention, compounds such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N- (5-Fluoropyridin-2-yl)cyclopropanecarboxamide has been found to be a potent orexin receptor antagonist and is useful in the treatment of sleep disorders such as insomnia, among other therapeutic uses.
priorityDate 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO55232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54897
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GLF6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5732
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID317701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44377279
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO43612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426341006
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25723
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77668
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3680404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426272319
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44404987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15171
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571081
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID317701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO55241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470

Total number of triples: 60.